2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Diabetes Mellitus, Type 1 in 1 studies
2,2-bis(4-glycidyloxyphenyl)propane: structure
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botolin, S | 1 |
| McCabe, LR | 1 |
1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
Topics: Adipocytes; Animals; Benzhydryl Compounds; Biomarkers; Bone Marrow; Cell Differentiation; Cells, Cul | 2006 |